Effect of glucocorticoid deficiency after adrenalectomy on antitumor immunity

Y Hiramoto1, K Sugimachi

  • 1Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Insights

Glucocorticoid deficiency impairs antitumor immunity in mice. Supplementation with corticosterone restored immune response, highlighting glucocorticoids

Area of Science:

  • Immunology
  • Endocrinology
  • Oncology

Background:

  • Glucocorticoids are critical for immune system regulation.
  • Adrenalectomy (ADX) leads to glucocorticoid deficiency.
  • The role of glucocorticoids in antitumor immunity requires further elucidation.

Purpose of the Study:

  • To investigate the impact of corticosterone on antitumor immunity in adrenalectomized mice.
  • To determine the effect of stress on immune cell function in glucocorticoid-deficient states.

Main Methods:

  • Surgical adrenalectomy and sham adrenalectomy in mice.
  • Assessment of concomitant immunity and spleen cell cytotoxic activity.
  • Administration of supplementary corticosterone to adrenalectomized mice.

Main Results:

  • Adrenalectomized mice exhibited compromised antitumor immunity.
  • Corticosterone supplementation restored antitumor immunity in adrenalectomized mice.
  • Stress impaired spleen cell cytotoxic activity in corticosterone-supplemented adrenalectomized mice, but not in sham-operated mice.

Conclusions:

  • Glucocorticoid deficiency significantly compromises antitumor immune responses.
  • Glucocorticoids are essential for the maturation and function of immunocompetent cells involved in antitumor immunity.
  • Stress exacerbates immune deficits in glucocorticoid deficiency.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...